USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: NANOPARTICLE BIOCHEM, INC.
Address: 2814 WILD PLUM CT.
COLUMBIA, MO 65201-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $240,880.00 2
SBIR Phase II $1,002,558.00 1

Award List:

SBIR TOPIC 252 -COMMERCIALLY VIABLE SYNTHESIS OF MULTIFUNCTIONAL CANCER RECEPTOR

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Anandhi Upendran
Award Amount: $135,973.00
Abstract:
In this Phase I SBIR contract, Nanoparticle Biochem Inc (NBI) proposes to develop commercially viable synthetic methodology for the production of multifunctional gold Nanoparticle-bombesin conjugate. Gold Nanoparticle-bombesin (AuNP-BBN) conjugate is a pot ential clinical imaging and therapeutic… More

IN VIVO COMPATIBLE AND READILY INJECTABLE GOLD NANO CONSTRUCTS FOR TUMOR THERAPY

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wynn Volkert
Award Amount: $104,907.00
Abstract:
The objective of this proposal is to develop nanoparticulate therapeutic products from the readily injectable Gold-198 (Au-198) nanoconstructs invented at the University of Missouri and licensed to Nanoparticle Biochem, Inc. The Phase I effort embodies thr ee aims: (1) Optimization of synthetic… More

Not Available

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wynn Volkert
Award Amount: $1,002,558.00
Abstract:
As part of the SBIR Phase I effort, Nanoparticle Biochem Inc has successfully completed detailed therapeutic efficacy studies of NBI-29 (GA-198AuNP; GA = gum arabic) in prostate tumor bearing mice and toxicity studies of the non radioactive surrogate of NBI 29 in pigs. In order to clinically… More